20408946

Source:http://linkedlifedata.com/resource/pubmed/id/20408946

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0030705, umls-concept:C0045212, umls-concept:C0087111, umls-concept:C0524909, umls-concept:C0971023, umls-concept:C1707455
pubmed:issue	6
pubmed:dateCreated	2010-7-13
pubmed:abstractText	There has been no study comparing the clinical efficacy of clevudine and entecavir in antiviral-naïve patients with chronic hepatitis B (CHB).
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/101160857
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/2'-fluoro-5-methylarabinosyluracil, http://linkedlifedata.com/resource/pubmed/chemical/Alanine Transaminase, http://linkedlifedata.com/resource/pubmed/chemical/Antiviral Agents, http://linkedlifedata.com/resource/pubmed/chemical/Arabinofuranosyluracil, http://linkedlifedata.com/resource/pubmed/chemical/Biological Markers, http://linkedlifedata.com/resource/pubmed/chemical/DNA, Viral, http://linkedlifedata.com/resource/pubmed/chemical/Guanine, http://linkedlifedata.com/resource/pubmed/chemical/Hepatitis B e Antigens, http://linkedlifedata.com/resource/pubmed/chemical/entecavir
pubmed:status	MEDLINE
pubmed:month	Jul
pubmed:issn	1478-3231
pubmed:author	pubmed-author:ChoYong KyunYK, pubmed-author:JeonWoo KyuWK, pubmed-author:KimByung IkBI, pubmed-author:KimHong JooHJ, pubmed-author:ParkDong IlDI, pubmed-author:ParkJung HoJH, pubmed-author:SohnChong IlCI
pubmed:issnType	Electronic
pubmed:volume	30
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	834-40
pubmed:dateRevised	2010-11-18
pubmed:meshHeading	pubmed-meshheading:20408946-Adult, pubmed-meshheading:20408946-Alanine Transaminase, pubmed-meshheading:20408946-Antiviral Agents, pubmed-meshheading:20408946-Arabinofuranosyluracil, pubmed-meshheading:20408946-Biological Markers, pubmed-meshheading:20408946-DNA, Viral, pubmed-meshheading:20408946-Drug Resistance, Viral, pubmed-meshheading:20408946-Female, pubmed-meshheading:20408946-Genotype, pubmed-meshheading:20408946-Guanine, pubmed-meshheading:20408946-Hepatitis B, Chronic, pubmed-meshheading:20408946-Hepatitis B e Antigens, pubmed-meshheading:20408946-Hepatitis B virus, pubmed-meshheading:20408946-Humans, pubmed-meshheading:20408946-Kaplan-Meier Estimate, pubmed-meshheading:20408946-Male, pubmed-meshheading:20408946-Middle Aged, pubmed-meshheading:20408946-Muscular Diseases, pubmed-meshheading:20408946-Republic of Korea, pubmed-meshheading:20408946-Retrospective Studies, pubmed-meshheading:20408946-Time Factors, pubmed-meshheading:20408946-Treatment Outcome, pubmed-meshheading:20408946-Viral Load, pubmed-meshheading:20408946-Virus Replication
pubmed:year	2010
pubmed:articleTitle	Comparison between clevudine and entecavir treatment for antiviral-naïve patients with chronic hepatitis B.
pubmed:affiliation	Department of Internal Medicine, Division of Gastroenterology, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Korea. hongjoo3.kim@samsung.com
pubmed:publicationType	Journal Article, Comparative Study